title: Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b.
abstract: BACKGROUND
  Sarcoidosis is a multisystemic granulomatous disorder of unknown etiology that most commonly affects young adults. A probable induction of sarcoidosis by interferons (IFN) has been published. To this date, few cases of cutaneous sarcoidosis inpatients with chronic hepatitis C under interferon treatment have been reported.
  
  
  OBJECTIVE
  We describe a 50-year-old woman with chronic hepatitis C who developed lesions of cutaneous sarcoidosis three months after IFN treatment.
  
  
  CONCLUSIONS
  The possible role of INF therapy in the development of cutaneous sarcoidosis in a patient with chronic hepatitis C should be considered.
authors.affiliation: Dermatology Department, Argerich County Hospital, University of Buenos Aires, Colon 660, Burzaco, Buenos Aires 1852, Argentina. aafernan@infovia.com.ar
authors.forename: V
authors.initials: V
authors.lastname: Neglia
authors.forename: S
authors.initials: S
authors.lastname: Sookoian
authors.forename: M
authors.initials: M
authors.lastname: Herrera
authors.forename: A
authors.initials: A
authors.lastname: Abeldaño
authors.forename: M C
authors.initials: MC
authors.lastname: Kien
authors.forename: E
authors.initials: E
authors.lastname: Chouela
authors.forename: B
authors.initials: B
authors.lastname: Frider
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D012507:Sarcoidosis / Q000139:chemically induced* / Q000150:complications; D012871:Skin Diseases / Q000139:chemically induced* / Q000150:complications
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha